Gradually rising interest rates should widen operating margins for Citigroup and Lazard. Read More
Archive
Filter
Massive global boosts in infrastructure spending are benefiting income-oriented plays, not just growth stocks. Here are your top choices. Read More
This construction stalwart is well-positioned, but its growth needs to catch up with its valuation. Read More
Passage of the infrastructure spending bill should push Caterpillar and Cemex considerably higher in 2022. Read More
You Have Questions, We Have Answers Read More
Increased infrastructure spending, rising inflation, and higher interest rates are likely to be the dominant macroeconomic themes in the year to come. Read More
The Omicron variant of coronavirus emerges as an economic threat heading into 2022. Read More
The big-box retailer delivers another stellar quarter on strength of online and store sales. Read More
I do not believe the stagflation scenario is likely, but if it turns out that omicron is impervious to the current COVID-19 vaccines then that could send the global financial system into a tailspin. Read More
This month’s Personal Finance options recommendation includes two strategies, selling a covered call and selling a naked put on AbbVie (NYSE: ABBV) as described below. If you already own shares of AbbVie, then you should consider selling a covered call against that stock position, but if you do not yet… Read More